received

In August, a man, Parkinson’s medications Mirapex for his gambling addiction blamed 0.2 million in his lawsuit against the drug manufacturer, Boehringer Ingelheim Pharmaceuticals Inc., considered a barometer case and was observed by many of the strengths and weaknesses of to evaluate other Mirapex lawsuits. Now, many legal experts believe there is a good chance similar Mirapex lawsuits are successful will.

Mirapex is suspected of a class of medications called dopamine agonists, which have long been the cause compulsive behavior. Mirapex was treated by the Food & Drug Administration (FDA) in 1997 approved for Parkinson’s disease, and in 2006 it has been approved as a treatment of restless legs syndrome. Other dopamine agonists Parlodel, Dostinex, Requip, Apokyn and Neupro.

Parkinson’s disease is caused by a lack of dopamine, a neurotransmitter in specific brain regions. Dopamine in the brain movement and coordination centers in the brain and is also the pleasure response by reinforcing behaviors that give pleasure parties – including alcohol, drugs, sex and money.

For many patients with Parkinson’s disease, Mirapex provides much needed relief from tremor. But some doctors say that the dopamine agonists Mirapex and may encourage other impulsive behaviors. In some patients, Mirapex over-activates the pleasure centers in the brain. The biochemical reaction that Mirapex may lead some people to experience a “rush” when they expect a reward or excitement.

Several studies have shown a link between Mirapex and similar drugs and compulsive behaviors. was presented after a June at the International Congress of Parkinson’s disease and movement disorders conference in Chicago, more than 13 percent of 3090 patients with Parkinson’s a problem with gambling, buying, sex or binge eating. The people who had either Mirapex or Requip occasion, two to three times more often one of the disorders of impulse control four.

Other studies have a similar relationship between, perhaps the most dramatic evidence linking Mirapex to this behavior is that in most cases, once the behavior is no longer the drug is discontinued shown. Unfortunately, many people who know these side effects are not that Mirapex could experience behind her strange behavior. Despite evidence that Mirapex caused impulse control behaviors from clinical studies in the 1990s, the drug manufacturer’s failure to issue warnings about the problem until 2005.

The impulse control Mirapex users have seen problems in bankruptcies, broken marriages, depression and even suicidal. Therefore, more than 200 lawsuits against Boehringer Ingelheim for Mirapex patients submitted because the users to warn of the drug associated with impulse control disorders.

Gary Charbonneau was one of these patients. Charbonneau, who began with Mirapex in December 1997, said he had a gambling addiction from March 2002 to February 2006. During this time he played 0000th The case was before the District Court of the United States in Minneapolis, where hundreds of lawsuits consolidated Mirapex have been heard.

Charbonneau continue not only argued that Mirapex caused his gambling debt problem, but drug companies Pfizer and Boehringer Ingelheim, knew its potential to cause compulsive behavior, but do not have any warnings issued or steps to investigate the true extent of the problem.

Boehringer Ingelheim and Pfizer Inc., which had distributed the drug in the United States argues, hey not responsible for the reported dependence Charbonneau, because the FDA did not ask for any label changes that despite Mirapex caused compulsive behavior. The companies have also claimed that Charbonneau had gambling problems preceded its use Mirapex and went to stop taking the drug.

The jury that heard the case was not convinced by the arguments of the defendant. Charbonneau won all of its losses in the game, with 0.8 million in punitive damages. However, Boehringer Ingelheim and Pfizer expected to appeal the decision.

Charbonneau was a case be heard by three “indicator” of the cases, the dates to back-to-back in the Multidistrict Litigation. The tests will be used by other potential complainants, Mirapex, and to assess the defendants, their chances of success in other studies.


Eating Disorder Treatment Chicago